Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism

Regulation of Hepatic Gluconeogenesis by an ER-Bound Transcription Factor, CREBH

(2010) Min-Woo Lee et al.   Cell Metabolism

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance

(2010) P. J. F. Martins et al.   DIABETES

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

(2010) Shijie Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TORC2 Regulates Hepatic Insulin Signaling via a Mammalian Phosphatidic Acid Phosphatase, LIPIN1

(2009) Dongryeol Ryu et al.   Cell Metabolism

Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis

(2009) Young-Sil Yoon et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation

(2009) Young-Sil Yoon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

(2008) Won-il Jeong et al.   Cell Metabolism

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways

(2008) Keun-Gyu Park et al.   HEPATOLOGY

Olanzapine-induced Elevation of Serum Triglyceride Levels in a Normal Weight Patient with Schizophrenia

(2008) Takahiko Nagamine   INTERNAL MEDICINE

The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain

(2008) Katrina Weston-Green et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

(2008) Douglas Osei-Hyiaman et al.   JOURNAL OF CLINICAL INVESTIGATION

Olanzapine (LY170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Benzodiazepine), but Not the Novel Atypical Antipsychotic ST2472 (9-Piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), Chronic Administration Induces Weight Gain, Hyperphagia, and Metabolic Dysregulation in Mice

(2008) R. Coccurello et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course

(2008) Stefan Gebhardt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint

(2008) Dana M. Gwinn et al.   MOLECULAR CELL